Patents by Inventor Chi-Tai Yeh

Chi-Tai Yeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for enhancing effect of immunotherapy for cancer
    Patent number: 10478468
    Abstract: Disclosed is a method for enhancing the effect of an immunotherapy for cancer in a subject, comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus. Also disclosed is a method for increasing a subject's pool of M1 macrophages, wherein the subject is suffering from one or more conditions associated with undesirable M2 macrophage activation, the method comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: November 19, 2019
    Assignee: PHYTOHEALTH CORPORATION
    Inventors: Liang-Shun Wang, Chi-Tai Yeh, Chun-Hung Wu, Yi-Li Lee
  • METHOD FOR ENHANCING EFFECT OF IMMUNOTHERAPY FOR CANCER
    Publication number: 20180125912
    Abstract: Disclosed is a method for enhancing the effect of an immunotherapy for cancer in a subject, comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus. Also disclosed is a method for increasing a subject's pool of M1 macrophages, wherein the subject is suffering from one or more conditions associated with undesirable M2 macrophage activation, the method comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus.
    Type: Application
    Filed: November 9, 2017
    Publication date: May 10, 2018
    Applicant: PHYTOHEALTH CORPORATION
    Inventors: Liang-Shun WANG, Chi-Tai YEH, Chun-Hung WU, Yi-Ii LEE
  • Method for Inhibiting Growth of Ovarian Cancer Cells
    Publication number: 20180050012
    Abstract: The present invention is directed to a method for inhibiting growth of ovarian cancer cells in a subject in need thereof, comprising administering to said subject a composition comprising an effective amount of 4-acetyl-antroquinonol B or a pharmaceutical acceptable salt thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 22, 2018
    Applicant: NEW BELLUS ENTERPRISES CO., LTD.
    Inventors: CHUN-CHIH HUANG, YEW-MIN TZENG, CHI-TAI YEH, Tsang-Hsien Alexander Wu
  • Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer
    Patent number: 9138422
    Abstract: The present invention provides a method for inhibiting the growth of cancer stem cells, particularly colorectal cancer stem cells, liver cancer stem cells, lung cancer stem cells or breast cancer stem cells, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of antimycin A or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: September 22, 2015
    Inventors: Chi-Ying F. Huang, Chi-Tai Yeh, Chun-Hung Wu, Yu-Wen Liu
  • METHOD FOR TREATING A CANCER CAUSED BY CANCER STEM CELLS
    Publication number: 20150231105
    Abstract: This invention provides a method for inhibiting tumor growth caused by cancer stem cells in a subject in need thereof, which comprises administering to the subject an effective amount of 4-acetyl-antroquinonol B.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 20, 2015
    Applicant: NEW BELLUS ENTERPRISES CO., LTD
    Inventors: Chun-Chih Huang, Chih-Chieh Chen, Lih-Geeng Chen, Yew-Min Tzeng, Chi-Tai Yeh, Tsang-Hsien Alexander Wu
  • Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer
    Patent number: 9045450
    Abstract: The present invention provides a method for preparing antrocin of pharmaceutically acceptable salts thereof via a series of gold-catalyzed cyclization to construct the (6-6-5) tricyclic core frame. The present invention also provides a use of a composition in preparing drugs for suppressing growth of non-small cell lung cancer cells, wherein the composition comprises an effective amount of antrocin or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: June 2, 2015
    Assignees: KAIYEW INVESTMENT CORP., JENISA BIOTECHNOLOGY CORP.
    Inventors: Zhen Yang, Yew-Min Tzeng, Chuang-Chuang Li, Tuo-Ping Luo, Hang Shi, Chi-Tai Yeh
  • METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELL
    Publication number: 20140045841
    Abstract: The present invention provides a method for inhibiting the growth of cancer stem cells, particularly colorectal cancer stem cells, liver cancer stem cells, lung cancer stem cells or breast cancer stem cells, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of antimycin A or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 18, 2013
    Publication date: February 13, 2014
    Inventors: Chi-Ying F. Huang, Chi-Tai Yeh, Chun-Hung Wu, Yu-Wen Liu
  • Antrocin containing pharmaceutical compositions for inhibiting cancer cells
    Patent number: 8580847
    Abstract: This subject invention is directed to a method for inhibition of cancer cells, comprising administrating an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, wherein the cancer cells are selected from colorectal cancer cells, liver cancer cells, lung cancer cells or breast cancer cells.
    Type: Grant
    Filed: December 27, 2011
    Date of Patent: November 12, 2013
    Assignee: Chaoyang University of Technology
    Inventors: Yew-Min Tzeng, Tien-Shen Yang, Chi-Tai Yeh Yeh
  • METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS
    Publication number: 20120316164
    Abstract: The present invention provides a method for inhibiting the growth of cancer stem cells, particularly colorectal cancer stem cells, liver cancer stem cells, lung cancer stem cells or breast cancer stem cells, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of antimycin A or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 13, 2012
    Inventors: CHI-YING HUANG, CHI-TAI YEH, CHUN-HUNG WU, YU-WEN LIU
  • ANTROCIN CONTAINING PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CANCER CELLS
    Publication number: 20120100175
    Abstract: This subject invention is directed to a method for inhibition of cancer cells, comprising administrating an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, wherein the cancer cells are selected from colorectal cancer cells, liver cancer cells, lung cancer cells or breast cancer cells.
    Type: Application
    Filed: December 27, 2011
    Publication date: April 26, 2012
    Applicant: CHAOYANG UNIVERSITY OF TECHNOLOGY
    Inventors: Yew-Min Tzeng, Tien-Shen Yang, Chi-Tai Yeh
  • ANTROCIN CONTAINING PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CANCER CELLS
    Publication number: 20110263700
    Abstract: This subject invention is directed to a pharmaceutical composition for the inhibition of cancer cells, comprising an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 27, 2011
    Applicant: CHAOYANG UNIVERSITY OF TECHNOLOGY
    Inventors: Yew-Min Tzeng, Tien-Shen Yang, Chi-Tai Yeh